Hubert J. P. Schoemaker was a Dutch-American chemist and biotechnological pioneer. Schoemaker was a co-founder and the president of the Bio-tech company Centocor. He helped develop Remicade, a drug to treat auto-immune disorders like Crohn's disease and rheumatoid arthritis. After selling Centocor to Johnson and Johnson for $5.2 billion in 1999, Schoemaker went on to form Neuronyx, Inc. , a biotech company focused on developing cellular therapies.

PropertyValue
dbpprop:abstract
  • Hubert J. P. Schoemaker was a Dutch-American chemist and biotechnological pioneer. Schoemaker was a co-founder and the president of the Bio-tech company Centocor. He helped develop Remicade, a drug to treat auto-immune disorders like Crohn's disease and rheumatoid arthritis. After selling Centocor to Johnson and Johnson for $5.2 billion in 1999, Schoemaker went on to form Neuronyx, Inc. , a biotech company focused on developing cellular therapies. As of 2007, Neuronyx is in clinical trials testing adult bone marrow-derived cells in heart attack patients.
  • Hubert J. P. Schoemaker war ein niederländisch-US-amerikanischer Chemiker und Biotechnik-Pionier. Der geborene Niederländer Schoemaker war Gründer und ehemaliger Präsident der ersten US-amerikanischen Biotech-Firma Centocor. Schoemaker entwickelte Arzneistoffe, darunter das Krebsmittel "Medulloblastoma" und später Infliximab [Rheumamittel Remicade (D)].
dbpprop:birthPlace
dbpprop:deathPlace
dbpprop:hasPhotoCollection
dbpprop:name
  • Schoemaker, Hubert
dbpprop:shortDescription
  • chemist and bio-tech expert
dbpprop:wikiPageUsesTemplate
rdf:type
rdfs:comment
  • Hubert J. P. Schoemaker was a Dutch-American chemist and biotechnological pioneer. Schoemaker was a co-founder and the president of the Bio-tech company Centocor. He helped develop Remicade, a drug to treat auto-immune disorders like Crohn's disease and rheumatoid arthritis. After selling Centocor to Johnson and Johnson for $5.2 billion in 1999, Schoemaker went on to form Neuronyx, Inc. , a biotech company focused on developing cellular therapies.
  • Hubert J. P. Schoemaker war ein niederländisch-US-amerikanischer Chemiker und Biotechnik-Pionier. Der geborene Niederländer Schoemaker war Gründer und ehemaliger Präsident der ersten US-amerikanischen Biotech-Firma Centocor. Schoemaker entwickelte Arzneistoffe, darunter das Krebsmittel "Medulloblastoma" und später Infliximab [Rheumamittel Remicade (D)].
rdfs:label
  • Hubert Schoemaker
  • Hubert Schoemaker
owl:sameAs
skos:subject
foaf:givenname
  • Hubert
  • Hubert
foaf:name
  • Hubert Schoemaker
  • Hubert Schoemaker
foaf:page
foaf:surname
  • Schoemaker
  • Schoemaker
is dbpprop:name of
is owl:sameAs of